Project The AMARANTH Study – A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group,…
Basic data
Acronym:
The AMARANTH Study
Title:
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer´s Disease
Duration:
01/05/2015 to 30/04/2017
Abstract / short description:
In der Studie wird die Wirksamkeit einer 24-monatigen Therapie mit einem BACE1-inhibitor bei Patienten mit früher Alzheimer-Erkrankung untersucht.
Keywords:
Alzheimer
BACE1-Inhibitor
Involved staff
Managers
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Neurology with Focus on Epileptology
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Waltham, Massachusetts, United States of America